EUVIMEDEUVIMED entdecken
Crossref

Amgen, Inc. v. Sanofi: The Enablement Requirement of Patent Law: A Bargain for the People Stands the Test of Time

Jonathan Talos

Tulane Journal of Technology & Intellectual Property · 13.01.2025 · 26

DOI: 10.37381/c04h2v75 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tulane Journal of Technology & Intellectual Property, online erschienen am 13.01.2025. Verfasst von Jonathan Talos.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Talos, J. (2025). Amgen, Inc. v. Sanofi: The Enablement Requirement of Patent Law: A Bargain for the People Stands the Test of Time. Tulane Journal of Technology & Intellectual Property, 26. https://doi.org/10.37381/c04h2v75

Vancouver

Talos J. Amgen, Inc. v. Sanofi: The Enablement Requirement of Patent Law: A Bargain for the People Stands the Test of Time. Tulane Journal of Technology & Intellectual Property. 2025;26. doi:10.37381/c04h2v75

BibTeX
@article{Talos2025,
  author = {Talos, Jonathan},
  title = {Amgen, Inc. v. Sanofi: The Enablement Requirement of Patent Law: A Bargain for the People Stands the Test of Time},
  journal = {Tulane Journal of Technology & Intellectual Property},
  year = {2025},
  volume = {26},
  doi = {10.37381/c04h2v75}
}
Kostenlos starten →